VFEND Description

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each film-coated tablet also contains the following inactive ingredients: Tablet Core: Lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone, magnesium stearate Film-Coating: Hydroxypropyl methylcellulose, titanium dioxide, lactose monohydrate and triacetin.
The vial also contains sulfobutylether β-cyclodextrin sodium 3200 mg.
Upon reconstitution with water for injections, it produces a solution of 10 mg/mL Vfend and 160 mg/mL of sulfobutyl ether β-cyclodextrin sodium. The resultant solution is further diluted prior to administration as an IV infusion (see Dosage & Administration).
Voriconazole is (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol. It has an empirical formula of C₁₆H₁₄F₃N₅O and a molecular weight of 349.3.
Voriconazole is a white to light-colored powder.

voriconazole

Manufacturer:

Pfizer